Maternal serum glycosylated fibronectin may be a useful biomarker in first-trimester screening for preterm pre-eclampsia, according to new #UOGJournal study by Sokratous et al. which is #freetoread here: https://t.co/D37UJDAM6w
#ISUOG#LoveUltrasound@WileyHealth
"👏 Dr. Argyro Syngelaki delivered an impressive talk on the contribution of impaired placentation to preterm birth at the 20th World Congress in Fetal Medicine! Her insights shed light on a critical factor affecting preterm births, paving the way for targeted interventions and improved outcomes for both mothers and babies. Thank you, Dr. Syngelaki, for your valuable research! 🌍🤰 #PretermBirth #FetalMedicine"#FMF2023 @AAMoraitis@eli_vlacho@KingsCollegeLon@KingsCollegeNHS@lifecourse_KCL@NIHRresearch@NHSEngland@ArgyroSyngelaki@acog@RCObsGyn
"🔬 Dr. Nikolas Sokratous delivered a great talk on Serum glycosylated fibronectin as a potential new marker in preeclampsia! His research brings exciting prospects for early detection and management of this complex condition. Promising advancements like this pave the way for improved outcomes in maternal health. Thank you, Dr. Sokratous, for your valuable contribution! 🌟 #PreeclampsiaResearch #MedicalAdvancements" #FMF2023 @eli_vlacho@AAMoraitis #KyprosNicolaides
In this paper @pvondadelszen, @LauraAMagee1 & team show that although risks are greater with preterm pre-eclampsia, term disease is has AT LEAST equivalent total numbers of maternal adverse events.
Watch the video:
https://t.co/xD0oP3m3wt
Paper:
https://t.co/YBfmppMbjW
Just published in @TheLancet the INTERCOVID-2022 study:
Increased risks of poor pregnancy outcomes during the period of omicron as the variant of concern. Vaccine effectiveness is high. Data from 41 hospitals & 18 countries. @UniofOxford@Ox_wrh
https://t.co/5LytO2vwba
Cstitch in Lancet today. Monofilament suture did not reduce rate of pregnancy loss when compared with a braided suture (8 vs 7.6%). Monofilament sutures harder to remove (31.2vs 14.6%.) Less chorioamnionitis ? but not sepsis or pyrexia. ?Use what you like. https://t.co/Dgil4gZI0v
Happy to share this new study on the roles of Mir483 from Miguel Constancia lab, with key contributions from @ozannelab, and many current and past colleagues at @ObsGynaeCam, @IMS_MRL and elsewhere. Feedback is welcome.
https://t.co/viR65OvlZA
Yesterday, we published the primary results for the #DESiGNtrial (Detection of the Small for GestatioNal fetus), a randomised cluster control trial comparing implementation of the Growth Assessment Protocol (GAP) to standard care. 1/10 https://t.co/Qpf5LXCac4
Congratulations to Alex Moraitis for successful “defending” his PhD on “Ultrasound screening in the 3rd trimester” and a stimulating discussion with Prof Susan Ozanne. #CambridgeUniversity
Congratulations to @AAMoraitis, @gcs_smith and colleagues on their publication in @PLOSMedicine!
The authors recommend caution before introducing universal third-trimester screening for macrosomia. @CambridgeBRC